Cancer Research Consortium of West Michigan (CRCWM)

西密歇根癌症研究联盟 (CRCWM)

• 批准号: 10226962
• 负责人: KATHLEEN J YOST
• 金额: $ 218.43万
• 依托单位: SPECTRUM HEALTH HOSPITALS
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-08 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10226962
• 关键词: Address; Adolescent; Adolescent and Young Adult; Basic Science; Cancer Control; Cancer Patient; Caring; Child; Clinical; Clinical Trials; Communities; Community Clinical Oncology Program; Education; Elderly; Enrollment; Family; Geography; Goals; Grant; Health system; Image; Institutes; Leadership; Mentors; Michigan; Minority; Molecular; National Cancer Institute; National Clinical Trials Network; Newly Diagnosed; Oncology; Patients; Persons; Physicians; Population; Population Heterogeneity; Positioning Attribute; Prevention; Race; Recording of previous events; Research; Research Personnel; Rural; Socioeconomic Status; Target Populations; Toxic effect; Underinsured; Underserved Population; anticancer research; base; cancer care; cancer clinical trial; cancer diagnosis; cancer prevention; cancer survival; care delivery; clinical care; cost; ethnic minority population; experience; follow-up; health care disparity; improved; knowledge base; medical schools; precision medicine; programs; racial and ethnic; racial minority; research study; rural dwellers; symptom science; young adult

PROJECT SUMMARY The Cancer Research Consortium of West Michigan (CRCWM) is an NCI Community Oncology Research Program (NCORP) comprised of nine major health systems, a renowned basic science institute, and a medical school. CRCWM covers the west half of Michigan and cares for almost 14,000 newly diagnosed cancer patients and their families per year. Formed from two experienced Community Clinical Oncology Programs (CCOPs) in 2014, CRCWM has a 40+ year history of bringing clinical trials to the community and is a major accruer to NCI studies. With over 100 oncology physician investigators and a well-established administrative staff, CRCWM has the ability to enroll patients with cancer diagnoses across the continuum and to address NCI goals of expanding participation of racial/ethnic minorities and underserved in clinical trials. This application reiterates our commitment to high-quality research and ongoing alignment with NCI initiatives. We are well-positioned to achieve our specific aims for the next NCORP grant cycle which are: 1. To maximize accrual of patients to cancer clinical trials sponsored by the National Cancer Institute including priority studies for cancer control/prevention, molecular/precision medicine, and imaging. 2. To be strong contributors to Cancer Care Delivery Research (CCDR). 3. To maximize the sharing of NCI scientific findings into clinical care through education and engagement of clinical partners and health systems. 4. To address health care disparities experienced by underserved (e.g., rural, adolescent/young adult, elderly, minority and underinsured) populations within our communities. 5. To optimize our contribution to the national scientific research agenda by expanding our leadership and committee participation in the National Clinical Trials Network (NCTN)/NCORP research bases and the mentoring of young investigators.

项目摘要 西密歇根州（CRCWM）的癌症研究联盟是NCI社区肿瘤学 研究计划（NCORP）由九个主要卫生系统组成，这是一个著名的基本 科学研究所和一所医学院。 CRCWM覆盖了密歇根州的西半部，关心 每年将近14,000名新诊断的癌症患者及其家人。由两个形成 经验丰富的社区临床肿瘤学计划（CCOPS）在2014年，CRCWM拥有40多个 将临床试验带到社区的一年历史，并且是NCI研究的主要吸引力。 有100多名肿瘤医师调查员和成熟的行政人员， CRCWM能够在整个连续体中注册患者诊断患者 解决NCI扩大种族/族裔少数群体参与并服务不足的目标 临床试验。该应用程序重申了我们对高质量研究和正在进行的承诺 与NCI计划保持一致。 我们的位置良好，可以实现我们对下一个NCORP赠款周期的具体目标，该目标是： 1。最大化患者参加癌症的临床试验 癌症研究所包括癌症控制/预防的优先研究， 分子/精度药物和成像。 2。成为癌症护理递送研究（CCDR）的有力贡献者。 3。通过教育最大化NCI科学发现在临床护理中 以及临床合作伙伴和卫生系统的参与。 4。解决服务不足的医疗保健差异（例如，农村， 青少年/年轻人，老年人，少数群体和保险人口不足） 社区。 5。通过扩展我们的国家科学研究议程来优化我们对国家科学研究议程的贡献 领导和委员会参加国家临床试验网络 （NCTN）/NCORP研究基础和年轻研究人员的指导。